Press Release

NAMSA Expands Service Offering Expertise Into South America

In Clinical, MRO, News, Preclinical, Press Release by Sean Hamilton

Northwood, OH – October 2015 – NAMSA, the world’s leading medical research organization is pleased to announce the addition of Blanchard & Associates as NAMSA’s local agent in South America.

Blanchard & Associates is a clinical research organization (CRO) with extensive clinical study experience executed for clients throughout Latin America.

Blanchard & Associates offers services including; clinical research, preclinical testing expertise, regulatory and quality guidance, and government affairs.  NAMSA and Blanchard & Associates have collaborated on several global clinical studies over the years and will now be partnering to offer NAMSA’s global regulatory and testing support for Latin American device manufacturers and clients expanding into the geography.

“Blanchard & Associates is excited to bring our Latin American expertise into NAMSAs longstanding best in class reputation to support the life cycle of medical devices,” said Anne Blanchard, CEO and Director of Clinical Operations at Blanchard & Associates. “We are already executing clinical trials in partnership with NAMSA and look forward to further supporting local device developers with their R&D and global market entry expertise.”

“The addition of Blanchard & Associates as a NAMSA agent demonstrates our commitment to the continued growth of service offerings for our clients around the world,” stated John Amat, NAMSA Vice President of Sales and Marketing. “Their expertise in the Latin American market for clinical research, preclinical testing, and regulatory consulting provides our clients access to their knowledge and network through their NAMSA partnership, something other CRO’s cannot provide their clients.”

About Blanchard & Associates
Blanchard & Associates ( is a clinical research organization (CRO) founded by professionals with over 20 years of experience in Clinical Research, in operations for more than 7 years, and has executed numerous clinical studies for clients throughout South America.

NAMSA ( is the global medical research organization, providing comprehensive services to advise clients and evaluate the safety and efficacy of medical devices, IVDs and combination products. For nearly 50 years, NAMSA clients have utilized its consulting, testing and clinical services to bring safe and effective therapies to market.

Contact information
For further information about NAMSA or this news release, contact:
John Amat
Corporate Vice President Global Sales & Marketing
6750 Wales Rd Northwood, OH 43619


Sean Hamilton is a senior marketer, communicator, writer and creative director of brands, marketing collateral and campaigns. He has spent his last 6 years supporting the Medical Device Industry through continued insights and thought leadership materials to help bring best practices and ideas to the forefront of communications and trade discussions industry-wide.